DECITABINE for Myeloid leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where DECITABINE was used for Myeloid leukaemia.
Most Reported Side Effects for DECITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 336 | 11.3% | 92 | 223 |
| Off label use | 292 | 9.8% | 75 | 98 |
| Drug ineffective | 253 | 8.5% | 63 | 60 |
| Pneumonia | 243 | 8.2% | 120 | 98 |
| Myelosuppression | 233 | 7.8% | 30 | 93 |
| Product use in unapproved indication | 195 | 6.5% | 59 | 17 |
| Neutropenia | 193 | 6.5% | 64 | 69 |
| Sepsis | 175 | 5.9% | 99 | 81 |
| Acute myeloid leukaemia | 172 | 5.8% | 92 | 52 |
| Thrombocytopenia | 170 | 5.7% | 31 | 50 |
| Disease progression | 156 | 5.2% | 55 | 33 |
| Death | 140 | 4.7% | 139 | 25 |
| Pyrexia | 137 | 4.6% | 22 | 104 |
| Infection | 126 | 4.2% | 55 | 23 |
| Nausea | 118 | 4.0% | 18 | 36 |
Other Indications for DECITABINE
Acute myeloid leukaemia (1,400)
Myelodysplastic syndrome (429)
Product used for unknown indication (253)
Acute myeloid leukaemia refractory (71)
Chemotherapy (70)
Chronic myelomonocytic leukaemia (67)
Acute lymphocytic leukaemia (54)
Acute myeloid leukaemia recurrent (49)
Myeloproliferative neoplasm (37)
Bone marrow conditioning regimen (34)
Other Drugs Used for Myeloid leukaemia
DASATINIB (411)
VENETOCLAX (197)
IMATINIB (163)
CYTARABINE (127)
PONATINIB (110)
NILOTINIB (105)
BOSUTINIB (83)
AZACITIDINE (62)
ENASIDENIB (58)
RUXOLITINIB (57)